Related Experiment Video
Updated: Apr 28, 2026
Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
How should we regulate risk in biomedical research? An ethical analysis of recent policy proposals and initiatives
1Department of Social Science, Health & Medicine, King's College London, United Kingdom.
Abstract:
The existing regulatory framework for research is increasingly attacked for its "one-size-fits-all" approach. Many stakeholders contend that existing regulations formulate the same regulatory requirements for research involving very different levels of risk, and thereby unnecessarily stifle medical progress. To address this criticism, regulators are currently developing more risk-adapted approaches to regulating research. A key feature of these approaches is that they aim to calibrate subject protections, including ethical review and safety monitoring, to the risks that studies pose to participants. Risk-adapted systems of research oversight are ethically appealing because they have the potential to promote research within the constraints of adequate subject protection. However, this potential can only be realized if the complexities surrounding research risk can be addressed. The present paper offers the first systematic overview and ethical analysis of how European and U.S. regulators approach the development of more risk-adapted regulations. The analysis finds that so-called stratified approaches are ethically preferable because they specify risk categories with corresponding subject protections, and thereby reduce unwarranted variation in how research participants are protected in different studies. But the recent proposals for stratifying risk and subject protections raise various ethical concerns, for example regarding the accuracy of risk categories. Building on this analysis, the paper develops recommendations for future policy.
Insights
Regulators are developing risk-adapted research oversight to better protect participants. Stratified approaches are ethically preferred but raise concerns about risk category accuracy.
Area of Science:
- Medical Ethics
- Regulatory Science
- Clinical Research Governance
Background:
- Current research regulations face criticism for a "one-size-fits-all" approach.
- This rigid framework may stifle medical progress by imposing uniform requirements regardless of research risk.
- Stakeholders advocate for more flexible, risk-adapted regulatory systems.
Purpose of the Study:
- To provide a systematic overview and ethical analysis of European and U.S. regulatory approaches to risk-adapted research oversight.
- To evaluate the ethical implications of calibrating subject protections to study risks.
- To inform future policy development for research regulation.
Main Methods:
- Systematic review and ethical analysis of current regulatory frameworks in Europe and the U.S.
- Examination of proposed risk-adapted and stratified approaches to research oversight.
- Analysis of ethical considerations related to risk categorization and subject protection.
Main Results:
- Risk-adapted systems, particularly stratified approaches, are ethically preferable for aligning subject protections with research risks.
- Stratified approaches can reduce unwarranted variation in participant protection across different studies.
- Concerns exist regarding the accuracy and implementation of proposed risk categories.
Conclusions:
- Risk-adapted regulatory frameworks hold potential for advancing research while ensuring adequate participant protection.
- Stratified risk categories offer an ethically sound model but require careful attention to accuracy.
- Recommendations are provided for future policy to refine risk-adapted research regulation.
